Their findings revealed a significantly greater increase in COMP levels in post-COVID-19 osteoarthritis patients compared to those with primary knee osteoarthritis, suggesting a potential exacerbating effect of SARS-CoV-2 on cartilage metabolism and joint pathology [33]. Here, COMP is linked to COVID-19.